219 related articles for article (PubMed ID: 33507976)
21. Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy.
Sha L; Wang X; Li J; Shi X; Wu L; Shen Y; Xu Q
J Exp Med; 2017 Feb; 214(2):547-563. PubMed ID: 28028152
[TBL] [Abstract][Full Text] [Related]
22. Targeted overexpression of glutamate transporter-1 reduces seizures and attenuates pathological changes in a mouse model of epilepsy.
Peterson AR; Garcia TA; Cullion K; Tiwari-Woodruff SK; Pedapati EV; Binder DK
Neurobiol Dis; 2021 Sep; 157():105443. PubMed ID: 34246771
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal Synaptic Dysfunction in a Mouse Model of Huntington Disease Is Not Alleviated by Ceftriaxone Treatment.
Wilkie CM; Barnes JR; Benson CM; Brymer KJ; Nafar F; Parsons MP
eNeuro; 2020; 7(3):. PubMed ID: 32354757
[TBL] [Abstract][Full Text] [Related]
24. Changes in the glutamate biomarker expression in rats vulnerable or resistant to the rewarding effects of cocaine and their reversal by ceftriaxone.
Niedzielska-Andres E; Mizera J; Sadakierska-Chudy A; Pomierny-Chamioło L; Filip M
Behav Brain Res; 2019 Sep; 370():111945. PubMed ID: 31100299
[TBL] [Abstract][Full Text] [Related]
25. Ceftriaxone Treatment Preserves Cortical Inhibitory Interneuron Function via Transient Salvage of GLT-1 in a Rat Traumatic Brain Injury Model.
Hameed MQ; Hsieh TH; Morales-Quezada L; Lee HHC; Damar U; MacMullin PC; Hensch TK; Rotenberg A
Cereb Cortex; 2019 Dec; 29(11):4506-4518. PubMed ID: 30590449
[TBL] [Abstract][Full Text] [Related]
26. GLT-1 Knockdown Inhibits Ceftriaxone-Mediated Improvements on Cognitive Deficits, and GLT-1 and xCT Expression and Activity in APP/PS1 AD Mice.
Gao J; Liu L; Liu C; Fan S; Liu L; Liu S; Xian XH; Li WB
Front Aging Neurosci; 2020; 12():580772. PubMed ID: 33132901
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury.
Cui C; Cui Y; Gao J; Sun L; Wang Y; Wang K; Li R; Tian Y; Song S; Cui J
Neurol Sci; 2014 May; 35(5):695-700. PubMed ID: 24277205
[TBL] [Abstract][Full Text] [Related]
28. Sulbactam improves binding property and uptake capacity of glutamate transporter-1 and decreases glutamate concentration in the CA1 region of hippocampus of global brain ischemic rats.
Gu WW; Cui X; Liu LZ; Zhang M; Li WB; Xian XH
Amino Acids; 2021 Nov; 53(11):1649-1661. PubMed ID: 34716803
[TBL] [Abstract][Full Text] [Related]
29. Activation of p38 MAPK participates in the sulbactam-induced cerebral ischemic tolerance mediated by glial glutamate transporter-1 upregulation in rats.
Xian XH; Gao JX; Qi J; Fan SJ; Zhang M; Li WB
Sci Rep; 2020 Nov; 10(1):20601. PubMed ID: 33244020
[TBL] [Abstract][Full Text] [Related]
30. GLT-1 upregulation impairs prepulse inhibition of the startle reflex in adult rats.
Bellesi M; Melone M; Gubbini A; Battistacci S; Conti F
Glia; 2009 May; 57(7):703-13. PubMed ID: 18985735
[TBL] [Abstract][Full Text] [Related]
31. Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat.
Goodrich GS; Kabakov AY; Hameed MQ; Dhamne SC; Rosenberg PA; Rotenberg A
J Neurotrauma; 2013 Aug; 30(16):1434-41. PubMed ID: 23510201
[TBL] [Abstract][Full Text] [Related]
32. Chronic ceftriaxone treatment rescues hippocampal memory deficit in AQP4 knockout mice via activation of GLT-1.
Yang J; Li MX; Luo Y; Chen T; Liu J; Fang P; Jiang B; Hu ZL; Jin Y; Chen JG; Wang F
Neuropharmacology; 2013 Dec; 75():213-22. PubMed ID: 23973312
[TBL] [Abstract][Full Text] [Related]
33. Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression.
LaCrosse AL; Hill K; Knackstedt LA
Eur Neuropsychopharmacol; 2016 Feb; 26(2):186-194. PubMed ID: 26706696
[TBL] [Abstract][Full Text] [Related]
34. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats.
Hu Y; Li W; Lu L; Cai J; Xian X; Zhang M; Li Q; Li L
Pain; 2010 Feb; 148(2):284-301. PubMed ID: 20022427
[TBL] [Abstract][Full Text] [Related]
35. Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-κB signaling pathway.
Feng D; Wang W; Dong Y; Wu L; Huang J; Ma Y; Zhang Z; Wu S; Gao G; Qin H
Neuroscience; 2014 May; 268():21-32. PubMed ID: 24631672
[TBL] [Abstract][Full Text] [Related]
36. Dehydroepiandrosterone's antiepileptic action in FeCl3-induced epileptogenesis involves upregulation of glutamate transporters.
Mishra M; Singh R; Mukherjee S; Sharma D
Epilepsy Res; 2013 Sep; 106(1-2):83-91. PubMed ID: 23891458
[TBL] [Abstract][Full Text] [Related]
37. Up-regulated GLT-1 resists glutamate toxicity and attenuates glutamate-induced calcium loading in cultured neurocytes.
Liu CH; Jiao H; Guo ZH; Peng Y; Wang WZ
Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):19-24. PubMed ID: 22998524
[TBL] [Abstract][Full Text] [Related]
38. Riluzole elevates GLT-1 activity and levels in striatal astrocytes.
Carbone M; Duty S; Rattray M
Neurochem Int; 2012 Jan; 60(1):31-8. PubMed ID: 22080156
[TBL] [Abstract][Full Text] [Related]
39. Loss of the glutamate transporter splice-variant GLT-1b in inferior colliculus and its prevention by ceftriaxone in thiamine deficiency.
Jhala SS; Wang D; Hazell AS
Neurochem Int; 2011 Apr; 58(5):558-63. PubMed ID: 21256174
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.
Miller BR; Dorner JL; Shou M; Sari Y; Barton SJ; Sengelaub DR; Kennedy RT; Rebec GV
Neuroscience; 2008 Apr; 153(1):329-37. PubMed ID: 18353560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
